HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ashtary, F. Articles by Bahrami, A. Search for Related Content PubMed PubMed Citation Articles by Ashtary, F. Articles by Bahrami, A.

A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke

From the Department of Neurology and Epidemiology, Isfahan University of Medical Sciences and Health Services, Iran.

Address correspondence and reprint requests to Dr. Mohsen Janghorbani, Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran; e-mail: janghorbani{at}yahoo.com

The authors assessed the efficacy of bromocriptine in nonfluent aphasia after stroke in a 16-week, randomized, double-blind, placebo-controlled clinical trial conducted from June 2002 to April 2004. In all 38 patients after 4 months of treatment, improvement in both the bromocriptine and placebo treatment groups was observed (p < 0.001). The analysis of repeated-measures analysis of variance revealed bromocriptine did not improve nonfluent aphasia.

Supported in part by grants from the Isfahan University of Medical Sciences, Isfahan, Iran.

Disclosure: The authors report no conflicts of interest.

Received June 20, 2005. Accepted in final form December 12, 2005.